Therapeutic and diagnostic agents
CA 2507709 A1 · Owner: The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland · Inventors: Clark, Georgina Jane; Hart, Derek Nigel John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to therapeutic and diagnostic agents. More particularly, the present invention provides molecules having structural features characteristic of immunoregulatory signalling (IRS) molecules and which are expressed by cells of haematopoietic lineages such as in , particular, leukocytes. The molecules of the present invention find broad application inter alia as diagnostic markers for cells targets for cell , therapy and as validated drug targets in order to modulate the immune response and to treat, prevent and diagnose a range of diseases conditions including cancer, genetic disease, inflammatory conditions and conditions associated with aberrant …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 28, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 28, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 28, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.